NDC 66992-425
Conjupri
Levamlodipine
Conjupri is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Wraser Llc. The primary component is Levamlodipine Maleate.
| Product ID | 66992-425_d3ae6eb7-8c36-1c0f-e053-2a95a90aa4a6 |
| NDC | 66992-425 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Conjupri |
| Generic Name | Levamlodipine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-08-15 |
| Marketing Category | NDA / |
| Application Number | NDA212895 |
| Labeler Name | WraSer LLC |
| Substance Name | LEVAMLODIPINE MALEATE |
| Active Ingredient Strength | 3 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 66992-425-30
30 TABLET in 1 BOTTLE (66992-425-30)
| Marketing Start Date | 2021-08-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "Conjupri" or generic name "Levamlodipine"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 24075-0410 | Conjupri | levamlodipine |
| 24075-0411 | Conjupri | levamlodipine |
| 24075-0412 | Conjupri | levamlodipine |
| 24075-0413 | Conjupri | levamlodipine |
| 66992-425 | Conjupri | levamlodipine |
| 66992-430 | Conjupri | levamlodipine |
| 69101-512 | Conjupri | levamlodipine maleate |
| 69101-525 | Conjupri | levamlodipine maleate |
| 69101-550 | Conjupri | levamlodipine maleate |
| 42195-425 | Levamlodipine | levamlodipine |
| 42195-450 | Levamlodipine | levamlodipine |
Trademark Results [Conjupri]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CONJUPRI 88716966 not registered Live/Pending |
Conjupro Biotherapeutics Inc. 2019-12-05 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.